Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Finished Goods (2018 - 2019)

Lexaria Bioscience's Finished Goods history spans 2 years, with the latest figure at $41415.0 for Q1 2019.

  • Quarterly results put Finished Goods at $41415.0 for Q1 2019, changed N/A from a year ago — trailing twelve months through Feb 2019 was $41415.0 (changed N/A YoY), and the annual figure for FY2018 was $9752.0, changed.
  • Finished Goods for Q1 2019 was $41415.0 at Lexaria Bioscience, up from $9752.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $41415.0 in Q1 2019 to a low of $9752.0 in Q3 2018.